People: Athersys Inc (ATHX.OQ)

ATHX.OQ on NASDAQ Stock Exchange Capital Market

1.62USD
17 Jun 2013
Price Change (% chg)

$0.00 (+0.00%)
Prev Close
$1.62
Open
$1.63
Day's High
$1.64
Day's Low
$1.61
Volume
20,516
Avg. Vol
115,243
52-wk High
$2.41
52-wk Low
$0.95

Search Stocks

Deans, Robert 

Brief Biography

Dr. Robert J. Deans, Ph.D., is Executive Vice President - Regenerative Medicine of Athersys Inc., since June 2011. Dr. Deans has led Athersys’ regenerative medicine research and development activities since February 2003, initially as Vice President of Regenerative Medicine, until he was named Senior Vice President of Regenerative Medicine in June 2006, and Executive Vice President in June 2011. Dr. Deans is regarded as an experienced in stem cell therapeutics, with over fifteen years of experience in this field. From 2001 to 2003, Dr. Deans worked for early-stage biotechnology companies. Dr. Deans was formerly the Vice President of Research at Osiris, a biotechnology company, from 1998 to 2001 and Director of Research and Development with the Immunotherapy Division of Baxter International, Inc., a global healthcare company, from 1992 to 1998. Dr. Deans was also previously on faculty at USC Medical School in Los Angeles, between 1981 and 1998, in the departments of Microbiology and Neurology at the Norris Comprehensive Cancer Center. Dr. Deans was an undergraduate at MIT, received his Ph.D. at the University of Michigan, and did his post-doctoral work at UCLA in Los Angeles.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
317,198 -- 5,620 322,818

Options Compensation

  Quantity Market Value
Excercisable -- --
Unexercisable -- --
Excercised -- --
Name Fiscal Year Total

Gil Van Bokkelen

457,120

William Lehmann

378,387

John Harrington

378,069

Robert Deans

322,818

Laura Campbell

245,774

Lee Babiss

--
As Of 30 Dec 2011
Search Stocks